![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 18, 8710-8715, Jun, 1988
AD Barone, J Ghrayeb, U Hammerling, MB Zucker and GJ Thorbecke
Centocor, Malvern, Pennsylvania 19355.
In order to establish more firmly the immunoregulatory effect of platelet factor 4 (PF4) and develop a means to provide material for possible clinical use, the nucleotide sequence for PF4 was synthesized utilizing a ligation strategy of six duplexes ranging from 27 to 43 base pairs in length. The individual oligodeoxynucleotides were synthesized on an automated system. The resultant gene segment (226 base pairs), which incorporated convenient HindIII and BamHI overhangs at the 5' and 3' ends, respectively, was cloned into the pIN-III-ompA-2- expression vector in Escherichia coli, affording a fusion protein of Mr = 8900 with 7 additional amino acids at the amino terminus and 4 at the carboxyl terminus and with aspartic acid rather than asparagine in position 47. The recombinant PF4 (rPF4) was purified by heparin-agarose affinity chromatography and reverse-phase high performance liquid chromatography. It reacted with a monoclonal mouse anti-human PF4 antibody on a Western blot and in an enzyme-linked immunosorbent assay. The rPF4 protein exhibited an immunoregulatory effect like that of human PF4 in its ability to reverse concanavalin A-induced immunosuppression in BALB/c mice.
This article has been cited by other articles:
![]() |
T. J. Daly, G. J. LaRosa, S. Dolich, T. E. Maione, S. Cooper, and H. E. Broxmeyer High Activity Suppression of Myeloid Progenitor Proliferation by Chimeric Mutants of Interleukin 8 and Platelet Factor 4 J. Biol. Chem., October 6, 1995; 270(40): 23282 - 23292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ehlert, F. Petersen, M. H. G. Kubbutat, J. Gerdes, H.-D. Flad, and E. Brandt Limited and Defined Truncation at the C Terminus Enhances Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2) J. Biol. Chem., March 17, 1995; 270(11): 6338 - 6344. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Williams, M. N. D'Ambra, T. E. Maione, K. E. Lynch, and D. F. Keene Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 975 - 983. [Abstract] [Full Text] |
||||
![]() |
T. Maione, G. Gray, J Petro, A. Hunt, A. Donner, S. Bauer, H. Carson, and R. Sharpe Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science, January 5, 1990; 247(4938): 77 - 79. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |